INB-200: PHASE 1 STUDY OF GENE MODIFIED AUTOLOGOUS GAMMA-DELTA (FΔ) T CELLS IN NEWLY DIAGNOSED GLIOBLASTOMA MULTIFORME (GBM) PATIENTS RECEIVING MAINTENANCE TEMOZOLOMIDE (TMZ)

The requested reference [a69904ae726f6819ffe0d5cee51ce5e92e4068de] no longer exists in our database. It has been replaced by the current reference: [61d3bcdd476f4b8bb71ca9c21738b0f937975245]

Authors
Category Primary study
JournalNeuro-Oncology
Year 2023
This article has no abstract
Epistemonikos ID: b247a33fee729048665756d720e58bb7294fdf25
First added on: Feb 17, 2025